Company profile

InventisBio

Small-molecule pharma (private)

Privately held: no public share price · China

Assets

(4 total)
4Total Assets
0Approved
4Phase 3 / Filed
0Phase 1–2 / Early
4Diseases
Quick filter:
Showing 4 of 4 assets
Target & Modality
D-0316
Phase 3
EGFRSmall molecule
Non-Small Cell Lung Cancer
D-0502
Phase 3
Estrogen receptorSmall molecule
HR+/HER2- Breast Cancer
HR+/HER2- Metastatic Breast Cancer
D-1553
Phase 3
KRAS G12CSmall molecule
Non-Small Cell Lung Cancer
D-2570
Phase 3
TYK2Small molecule
Inflammatory Bowel DiseasePsoriasis
Ulcerative Colitis

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.